Rent the Runway Inc vs GeneDx Holdings Corp — how do they compare? Rent the Runway Inc trades at $1.76 (market cap $61.75M), while GeneDx Holdings Corp trades at $67.29 (market cap $2.02B). The key difference: GeneDx Holdings Corp is far larger — about 32.7× Rent the Runway Inc's market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, Rent the Runway Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Rent the Runway Inc for 56 Days and GeneDx Holdings Corp for 19 Days on average.
| RENT | WGS | |
|---|---|---|
Market Cap | $61.75M | $2.02B |
Volume | 193,323 | 734,640 |
Sector | Consumer Cyclical | Health |
52-Week High | $9.39 | $167.51 |
52-Week Low | $1.55 | $34.51 |
Typical Hold Time | 56 Days | 19 Days |
Enterprise Value | $228.75M | $2.05B |
Signals from Pluang's Aura AI — not financial advice
RENT trades at $1.765, up 5.06% today, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The company reported revenue of $306.20M in 2025 with improving net loss margins, yet negative shareholder equity and high debt-to-asset ratios persist. Recent news includes a CEO appointment and multiple law firm investigations into investor claims, creating a complex sentiment backdrop.
The outlook remains challenged by financial instability and legal scrutiny, though analyst consensus leans buy with no sell ratings. Key risks include high leverage and ongoing losses, while potential upside hinges on execution of growth initiatives and margin improvement. Investors face significant volatility amid restructuring efforts.
GeneDx (WGS) trades at $68.09, down 0.64% today, with a bearish technical signal despite bullish oscillators showing oversold conditions. The company reported mixed Q2 2026 results with revenue beating expectations but negative profitability metrics, including a -23.4% net income margin. Recent news highlights product launches and industry recognition, while analyst consensus remains strongly bullish with a $81 price target.
The stock presents a growth opportunity in genomic testing with strong analyst support, but faces significant execution risks from persistent losses and high valuation multiples. Key catalysts include continued revenue growth and path to profitability, while risks include competitive pressures and cash flow challenges from negative operating cash flow in 2026.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Rent the Runway Inc is an e-commerce platform that allows users to rent, subscribe, or buy designer apparel and accessories.
Read more on RENT →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →